Large gap with delayed quotes
|
Last quote
12/27/2024 -
16:30:00
|
Bid
12/27/2024 -
15:59:59
|
Bid Volume |
Ask
12/27/2024 -
15:59:59
|
Ask Volume |
|---|---|---|---|---|
|
47.36
-1.18
(
-2.43% )
|
47.35
|
3,500 |
47.46
|
400 |
Analysis date: 24.12.2024
Global Evaluation
Neutral
Neutral
The stock is classified in the neutral zone since 25.10.2024.
Interest
Very weak
Very weak
Very weak interest since 17.12.2024.
Earnings Rev Trend
Positive
Positive
Compared to seven weeks ago, the analysts have raised their earnings per share estimates. This positive trend began 17.12.2024 at a price of 47.78.
Evaluation
Strongly overvalued
Strongly overvalued
Based on its growth potential and our own criteria, at its current price the stock is strongly overvalued.
MT Tech Trend
Negative
Negative
The forty day Medium Term Technical Trend is negative since 15.11.2024. The confirmed Technical Reverse point (Tech Reverse + 1.75%) is
4wk Rel Perf
-4.30%
-4.30%
The four week relative underperformance versus SP500 is 4.30%.
Sensibility
Low
Low
The stock has been on the low-sensitivity level since 24.09.2024.
Bear Market Factor
Low
Low
On average, the stock has a tendency to minimize the drops in the index by -1.71%.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 3.40%.
Mkt Cap in $bn
5.78
5.78
With a market capitalization between $2 & $8bn, CYTOKINETICS is considered a mid-cap stock.
G/PE Ratio
-0.03
-0.03
A negative ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) indicates that either the forecasted growth is decelerating (negative annualized growth estimate) or the financial analysts are expecting a loss (negative estimated PE).
LT P/E
-13.91
-13.91
The estimated PE is negative: the financial analysts' earnings estimates forecast a loss.
LT Growth
-0.34%
-0.34%
The annualized growth estimate is for the current year to 2026.
Avg. Nb analysts
15
15
Over the last seven weeks, an average of 15 analysts provided earnings per share estimates.
Dividend Yield
0.00%
0.00%
The company is not paying a dividend.
Beta
88
88
For 1% of index variation, the stock varies on average by 0.88%.
Correlation
0.11
0.11
Stock movements are totally independent of index variations.
Value at Risk
5.82
5.82
The value at risk is estimated at USD 5.82. The risk is therefore 12.00%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
31.08.2005
31.08.2005